Schonfeld Strategic Advisors LLC Pro Qr Therapeutics N.V. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRQR
# of Institutions
53Shares Held
17.3MCall Options Held
26.2KPut Options Held
8.6K-
Privium Fund Management B.V.5.58MShares$21.1 Million2.62% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$13.7 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.04MShares$7.72 Million0.12% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$3.85 Million1.95% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$3.42 Million0.39% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $270M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...